​

CNS Pharmaceuticals (CNSP) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChart

CNSP Stock Forecast

CNS Pharmaceuticals (CNSP) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $0.50, with a high of $0.50 and a low of $0.50. This represents a -46.24% decline from the last price of $0.93.

High: $0.5 Avg: $0.5 Low: $0.5 Last Closed Price: $0.93

CNSP Stock Rating

CNS Pharmaceuticals stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 3 Buy (75.00%), 1 Hold (25.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 1 3 Strong Sell Sell Hold Buy Strong Buy

CNSP Price Target Upside V Benchmarks

TypeNameUpside
StockCNS Pharmaceuticals-46.24%
SectorHealthcare Stocks 24.81%
IndustryBiotech Stocks 65.78%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$0.50
Last Closing Price$0.93$0.93$0.93
Upside/Downside---46.24%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Jun, 25-11--2
May, 25-11--2
Apr, 25-11--2
Mar, 2511---2
Feb, 2511---2
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Sep 10, 2024Jason McCarthyMaxim Group$0.50$0.15233.33%-46.24%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
May 22, 2025Alliance Global PartnersBuyBuyhold

Financial Forecast

EPS Forecast

$-450 $-350 $-250 $-150 $-50 $50 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-251.35$-38.87----
Avg Forecast$-426.50$-0.86$-0.27$-0.26$0.04$0.48
High Forecast$-426.50$-0.86$-0.27$-0.15$0.05$0.48
Low Forecast$-426.50$-0.86$-0.27$-0.36$0.02$0.48
Surprise %-41.07%4419.77%----

Revenue Forecast

$20M $32M $44M $56M $68M $80M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast--$23.20M$40.76M$43.49M$76.19M
High Forecast--$23.20M$40.76M$43.49M$76.19M
Low Forecast--$23.20M$40.76M$43.49M$76.19M
Surprise %------

Net Income Forecast

$-35M $-27M $-19M $-11M $-3M $5M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-18.85M$-14.86M----
Avg Forecast$-32.14M$-64.80K$-20.34K$-19.21K$2.64K$36.17K
High Forecast$-32.14M$-64.80K$-20.34K$-11.30K$3.77K$36.17K
Low Forecast$-32.14M$-64.80K$-20.34K$-27.13K$1.51K$36.17K
Surprise %-41.34%22829.06%----

CNSP Forecast FAQ

Is CNS Pharmaceuticals stock a buy?

CNS Pharmaceuticals stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 3 Buy, 1 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that CNS Pharmaceuticals is a favorable investment for most analysts.

What is CNS Pharmaceuticals's price target?

CNS Pharmaceuticals's price target, set by 4 Wall Street analysts, averages $0.5 over the next 12 months. The price target range spans from $0.5 at the low end to $0.5 at the high end, suggesting a potential -46.24% change from the previous closing price of $0.93.

How does CNS Pharmaceuticals stock forecast compare to its benchmarks?

CNS Pharmaceuticals's stock forecast shows a -46.24% downside, underperforming the average forecast for the healthcare stocks sector (24.81%) and underperforming the biotech stocks industry (65.78%).

What is the breakdown of analyst ratings for CNS Pharmaceuticals over the past three months?

  • June 2025: 0% Strong Buy, 50.00% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.
  • May 2025: 0% Strong Buy, 50.00% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 0% Strong Buy, 50.00% Buy, 50.00% Hold, 0% Sell, 0% Strong Sell.

What is CNS Pharmaceuticals’s EPS forecast?

CNS Pharmaceuticals's average annual EPS forecast for its fiscal year ending in December 2025 is $-0.27, marking a -99.31% decrease from the reported $-38.87 in 2024. Estimates for the following years are $-0.26 in 2026, $0.04 in 2027, and $0.48 in 2028.

What is CNS Pharmaceuticals’s revenue forecast?

CNS Pharmaceuticals's average annual revenue forecast for its fiscal year ending in December 2025 is $23.2M, reflecting a 0% decrease from the reported $0 in 2024. The forecast for 2026 is $40.76M, followed by $43.49M for 2027, and $76.19M for 2028.

What is CNS Pharmaceuticals’s net income forecast?

CNS Pharmaceuticals's net income forecast for the fiscal year ending in December 2025 stands at $-20.343K, representing a -99.86% decrease from the reported $-14.858M in 2024. Projections indicate $-19.214K in 2026, $2.64K in 2027, and $36.17K in 2028.